Immunogenicity of biliary epithelium: Investigation of antigen presentation to CD4+ T cells

Hepatology

Volumn 24, Issue 3, 1996, Pages 561-567

  Leon, Maria P ^a   Bassendine, Margaret F ^a   Wilson, Julia L ^a   Ali, Simi ^a   Thick, Michael ^a   Kirby, John A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELL INTERACTION; HEPATITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0029844861     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008781325     Document Type: Article

References (40)

1. Vierling JM. Immune disorders of the liver and bile duct. Gastroenterol Clin North Am 1992;21:427-449.
2. Krams SM, Ascher NL, Martinez OM. New immunologic insights into mechanisms of allograft rejection. Gastroenterol Clin North Am 1993;22: 381-400.
3. Saidman SL, Duquesnoy RJ, Zeevi A, Fung JJ, Starzl TE, Demetris AJ. Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes. HEPATOLOGY 1991;13:239-246.
4. Williams FH, Thiele DL. The role of major histocompatibility complex and non-major histocompatibility complex encoded antigens in generation of bile duct lesions during hepatic graft-vs.-host responses mediated by helper or cytotoxic T cells. HEPATOLOGY 1994;19:980-988.
5. Wiesner RH, Ludwig J, Van Hoek B, Krom RAF. Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure. HEPATOLOGY 1991;14:721-728.
6. Onishi S, Saibara T, Nakata S, Maeda T, Iwasaki S, Iwamura S, Miyazaki M, et al. Cytotoxic activity of spleen-derived T lymphocytes against autologous biliary epithelial cells in autopsy patients with primary biliary cirrhosis. Liver 1993;13:188-192.
7. Ballardini G, Mirakian R, Bianchi FB, Pisi E, Doniach D, Bottazo GF. Aberrant expression of HLA-DR antigens on bile duct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet 1984;2:1009-1013.
8. Floreani A, Bennett MK, Mitchison HC, McLachlan SM, Bassendine MF, James OFW. Progression of autoimmune damage in primary biliary cirrhosis: an immunohistochemical study. Autoimmunity 1989;2:311-321.
9. Volpes, Van Den Oord J, Desmet VJ. Vascular adhesion molecules in acute and chronic liver inflammation. HEPATOLOGY 1992;15:269-275.
10. Leon MP, Bassendine MF, Gibbs P, Burt A, Thick M, Kirby JA. Hepatic allograft rejection: regulation of the immunogenicity of human intrahepatic biliary epithelial cells. Liver Transplantation and Surgery 1996;2: 37-45.
11. Ayres RCS, Neuberger JM, Shaw J, Joplin R, Adams DH. Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of pro-inflammatory cytokines. Gut 1993;34:1245-1249.
12. Schwartz RH. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992; 71:1065-1068.
13. Janeway CA Jr, Bottomly K. Signals and signs for lymphocyte responses. Cell 1994;76:275-285.
14. Allison JP. CD28-B7 interactions in T-cell activation. Curr Opin Immunol 1994;6:414-419.
15. Leon MP, Kirby JA, Gibbs P, Burt AD, Bassendine MF. Immunogenicity of biliary epithelial cells: study of the expression of B7 molecules. J Hepatol 1995;22:591-595.
16. + T lymphocytes. J Immunol 1992;148:1985-1992.
17. Paroli M, Carloni G, Franco A, De Petrillo G, Alfani E, Perrone A, Barnaba V. Human hepatoma cells expressing MHC antigens display accessory cell function: dependence on LFA-1/ICAM-1 interaction. Immunology 1994;82: 215-221.
18. Savage COS, Brooks CJ, Harcourt GC, Picard JK, King W, Sansom DM, Willcox N. Human vascular endothelial cells process and present autoantigen to human T cell lines. Int Immunol 1995;7:471-479.
19. + T cell subsets with human vascular endothelial cells in primary proliferative allogeneic responses. Int Immunol 1993;5:1041-1048.
20. + allogeneic vascular endothelium: identification of accessory interactions. Transplantation 1993;56:128-134.
21. Kirby JA, Ikuta S, Clark K, Proud G, Lennard TWJ, Taylor RMR. Renal allograft rejection: investigation of alloantigen presentation by cultured human renal epithelial cells. Immunology 1991;72:411-417.
22. Geppert TD, Lipsky PE. Dissection of defective antigen presentation by interferon-gamma-treated fibroblasts. J Immunol 1987;138:385-392.
23. Gaspari AA, Katz SI. Induction and functional characterization of class II MHC (Ia) antigens on murine keratinocytes. J Immunol 1988;140:2956-2963.
24. Bland PW, Warren LG. Antigen presentation by epithelial cells of the rat small intestine. I. Kinetics, antigen specificity and blocking by anti-Ia antisera. Immunology 1986;58:1-7.
25. Singer GG, Yokoyama H, Bloom RD, Jernikar AM, Nabari N, Kellez VER. Stimulated renal tubular epithelial cells induce anergy in CD4+ve T cells. Kidney Int 1993;44:1030-1035.
26. Rossi GA, Sacco O, Balbi B. Human ciliated bronquial epithelial cells: expression of the HLA-DR antigens of the alpha gene, modulation of the HLA-DR antigens by gamma interferon and antigen presenting function in the mixed leukocyte reaction. Am J Respir Cell Mol Biol 1990;3:431.
27. Van Eyken P, Desmet VJ. Cytokeratins and the liver [Review]. Liver 1993; 13:113-122.
28. Freeman GJ, Freedman AS, Segil JM, Lee G, Whitman JF, Nadler LM. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J Immunol 1989;143:2714-2722.
29. Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, Somoza C. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993; 366:76-79.
30. Tokunaga K, Nakamura Y, Sakata K, Fujimori K, Ohkubo M, Sawada K, Sakiyama S. Enhanced expression of a glycer aldehyde-3-phosphate-dehydrogenase gene in human lung cancers. Cancer Res 1987;47:5616-5619.
31. Gearing AJH, Thorpe R. The international standard for human interleukin-2. Calibration by international collaborative study. J Immunol Methods 1988;114:3-9.
32. Tsuneyama K, Van de Water J, Leung PSC, Cha S, Nakanuma Y, Kaplan M, De Lellis R, et al. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression. HEPATOLOGY 1995;21:1031-1037.
33. Martins EB, Chapman RW, Fleming KA. Are bile duct epithelial cells capable of acting as professional antigen presenting cells in primary sclerosing cholangitis? [Abstract]. HEPATOLOGY 1995;22:109A.
34. Van Seventer GA, Shimizu Y, Horgan KJ, Shaw S. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol 1990;144:4579-4586.
35. Krieger JI, Chestnut RW, Grey HM. Capacity of B cells to function as stimulators of a primary mixed leukocyte reaction. J Immunol 1986;137: 3117-3123.
36. Van Oers MHJ, Pinkster J, Zeijlemaker WP. Quantification of antigen-reactive cells among human T lymphocytes. Eur J Immunol 1978;8:477-484.
37. Wilson JL, Proud G, Forsythe JLR, Taylor RMR, Kirby JA. Renal allograft rejection. Tubular epithelial cells present alloantigen in the presence of costimulatory CD28 antibody. Transplantation 1995;59:91-97.
38. Martin PJ, Ledbetter JA, Morishita Y, June CJ, Beatty PG, Hansen JA. A 44 kilodalton cell surface homodimer regulates interleukin 2 production by activated human T lymphocytes. J Immunol 1986;136:3282-3287.
39. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993;11:191-212.
40. Ledbetter JA, Imboden JB, Schieven GL, Grosmaire LS, Rabinovitch PS, Lindsten T, Thompson CB, et al. CD28 ligation in T-cell activation: evidence for two signal transduction pathways. Blood 1990;75:1531-1539.